Jonathan Chriqui Email & Phone Number

- Business Development- Financing- Launch Readiness- Communication

Zurich, CH

Operations: - Participate and establish a comprehensive business plan and guarantee its execution. - Prioritise tasks to secure the critical path of the project - Optimise timelines and budgets to reach target milestones on time - Follow and prepare deliverables to be presented in board meetings - Managing resources and budgets - Representing the image and.

Suresnes, FR

Contribute to the development of the Group drugs portfolio by actively looking for acquisition, licenses, products, or any other form of partnership, in the fields of metabolism (especially Diabetes) and Cardiology. - Strategy: Support strategy development initiatives to identify strategic business priorities; Definition of business development needs; Key.

Boulogne Billancourt, FR

Therapeutic areas: Neurology, Endocrinology, Primary Care - Gastroenterology, Oncology, OTX/C- Seek, screen, evaluate and financial valuation of Companies, new products and/or technologies. Strategy: Structure the Business Development approach by the implementation validation processes - Definition of business development needs; Key contributor to the.

Boulogne Billancourt, FR

- Structure the Business Development approach in the region by the implementation of a validation process: Design and impose templates for internal validation of any BD opportunity.Define process, mandatory information and presentation format.Create an internal alliance management team and include the input from all relevant functions of the company into.

Boulogne Billancourt, FR

Senior Regulatory product manager for Neurology (Dysport® (Botulinium toxin) and oncology (2 products under development)Intercontinental regulatory representative in charge of Neurology & Oncology franchise worldwide (except EU/US/Japan)Determination and Implementation of Regulatory strategy for the development purposes, in collaboration with the.

Indianapolis, Indiana, US

Responsible for biotech products: Humalog® - Umuline® (Endocrinology) and Medical devices / Xigris® - Reopro® (Intensive Care),Variations and renewals, modification of the medical information (SmPC – leaflet – packaging),Control of promotional material,Submission and Regulatory Follow-up on Clinical Trial (pilot phase),Regulatory follow-up on European.

Thousand Oaks, CA, US

« Pharmaceutical Establishment » (French specificity – Inspection and Audit), VariationsCompliance Audit – Standard Operating Procedures, Import Licence, Regulatory Follow-up on Clinical Trial and Compassionate Use program Evaluation promotional material, Validation of SmPC – package Insert leaflet, Regulatory Project manager for Kineret®.

Silver Spring, MD, US

@ CDER Division of Anti-Inflammatory, Analgesic and Ophthalmologic Drug Products (DAAODP), Washington DC USA.Regulatory Affairs intern: Investigational New Drugs (IND),  New Drug Application (NDA),  End of phase II meeting,  Work on COX-II inhibitors